Home / Research projects / OLIGOCARE "EORTC Study 1811 E²-RADIatE: European Radiotherapy Infrastructure of EORTC-ESTRO" Cohort: OligoCare 1822- Pragmatic observational study to evaluate radical radiotherapy in patients with oligo-metastatic cancer"
Share
OLIGOCARE "EORTC Study 1811 E²-RADIatE: European Radiotherapy Infrastructure of EORTC-ESTRO" Cohort: OligoCare 1822- Pragmatic observational study to evaluate radical radiotherapy in patients with oligo-metastatic cancer"
Project objectives
The aim of the study is to collect information regarding the radiotherapy treatment of oligometastatic patients affected by lung, prostate and colorectal cancers undergoing radiotherapy with ablative purposes.
Start and end date
January 28, 2020 - In progress
Project Manager
Sara Ramella - Principal Investigator
Coordinating institution of the project
Sponsor of the study: EORTC (European Organization for Research and Treatment of Cancer)